Prostate Cancer Treatment Market Report

China Prostate Cancer Treatment Industry Market Research Report 2023-2029

  • POSTDATE：Aug 31, 2023
  • PAGES：157
  • REPORT CODE：GMM1768179
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Prostate cancer is the most common cancer among men, the key risk factors for prostate cancer development is being old age, genetic, obesity and race.

    This report elaborates on the current development of the Prostate Cancer Treatment industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • AstraZeneca plc

    • Ipsen Pharma

    • Astellas Pharma Inc

    • Ferring Pharmaceuticals Inc

    • Takeda Pharmaceutical Company Ltd

    • F Hoffmann-La Roche AG

    • Bristol-Myers Squibb Company

    • Johnson & Johnson

    • Bayer AG

    By Type:

    • Radiochemotherapy

    • Other

    • Hormone therapy

    • Immunotherapy

    • Surgery

    • Targeted therapy

    By Application:

    • Non metastatic castration resistant prostate cancer (nmCRPC)

    • Metastatic castration resistant prostate cancer (mCRPC)

    • Localized prostate cancer

    • Metastatic hormone sensitive prostate cancer (mHSPC)

    • Recurrence of prostate cancer after curative treatment

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Prostate Cancer Treatment Market Overview 2018-2029

    • 1.1 China Prostate Cancer Treatment Industry Development Overview

    • 1.2 China Prostate Cancer Treatment Industry Development History

    • 1.3 China Prostate Cancer Treatment Industry Market Size (2018-2029)

    • 1.4 China Prostate Cancer Treatment Market Analysis by Type from Production Side

      • 1.4.1 China Prostate Cancer Treatment Production Volume, Production Value and Growth Rate of Radiochemotherapy (2018-2029)

      • 1.4.2 China Prostate Cancer Treatment Production Volume, Production Value and Growth Rate of Other (2018-2029)

      • 1.4.3 China Prostate Cancer Treatment Production Volume, Production Value and Growth Rate of Hormone therapy (2018-2029)

      • 1.4.4 China Prostate Cancer Treatment Production Volume, Production Value and Growth Rate of Immunotherapy (2018-2029)

      • 1.4.5 China Prostate Cancer Treatment Production Volume, Production Value and Growth Rate of Surgery (2018-2029)

      • 1.4.6 China Prostate Cancer Treatment Production Volume, Production Value and Growth Rate of Targeted therapy (2018-2029)

    • 1.5 China Prostate Cancer Treatment Market Analysis by Application from Consumption End

      • 1.5.1 China Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate of Non metastatic castration resistant prostate cancer (nmCRPC) (2018-2029)

      • 1.5.2 China Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate of Metastatic castration resistant prostate cancer (mCRPC) (2018-2029)

      • 1.5.3 China Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate of Localized prostate cancer (2018-2029)

      • 1.5.4 China Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate of Metastatic hormone sensitive prostate cancer (mHSPC) (2018-2029)

      • 1.5.5 China Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate of Recurrence of prostate cancer after curative treatment (2018-2029)

    • 1.6 China Prostate Cancer Treatment Market Analysis by Region

      • 1.6.1 North China Prostate Cancer Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Prostate Cancer Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Prostate Cancer Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Prostate Cancer Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Prostate Cancer Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Prostate Cancer Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Prostate Cancer Treatment Market Size and Growth Rate from 2018-2029

    Chapter 2 China Prostate Cancer Treatment Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Prostate Cancer Treatment Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Prostate Cancer Treatment Market Status and Competition Analysis in 2023

      • 2.2.3 China Prostate Cancer Treatment Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Prostate Cancer Treatment Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Prostate Cancer Treatment Industry Development

    Chapter 3 Prostate Cancer TreatmentIndustry Chain Analysis

    • 3.1 Prostate Cancer Treatment Industry Chain

    • 3.2 Prostate Cancer Treatment Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Prostate Cancer Treatment Market

    • 3.3 Prostate Cancer Treatment Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Prostate Cancer Treatment Market

    Chapter 4 China Prostate Cancer Treatment Market, by Type

    • 4.1 China Prostate Cancer Treatment Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Prostate Cancer Treatment Total Production Volume and Growth Rate from Production Side

    • 4.5 China Prostate Cancer Treatment Production Volume and Growth Rate, by Type

      • 4.5.1 China Prostate Cancer Treatment Production Volume and Growth Rate of Radiochemotherapy

      • 4.5.2 China Prostate Cancer Treatment Production Volume and Growth Rate of Other

      • 4.5.3 China Prostate Cancer Treatment Production Volume and Growth Rate of Hormone therapy

      • 4.5.4 China Prostate Cancer Treatment Production Volume and Growth Rate of Immunotherapy

      • 4.5.5 China Prostate Cancer Treatment Production Volume and Growth Rate of Surgery

      • 4.5.6 China Prostate Cancer Treatment Production Volume and Growth Rate of Targeted therapy

    Chapter 5 China Prostate Cancer Treatment Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Prostate Cancer Treatment Total Market Size and Growth Rate from Consumption End

    • 5.5 China Prostate Cancer Treatment Market Size and Growth Rate, by Application

      • 5.5.1 China Prostate Cancer Treatment Market Size and Growth Rate of Non metastatic castration resistant prostate cancer (nmCRPC)

      • 5.5.2 China Prostate Cancer Treatment Market Size and Growth Rate of Metastatic castration resistant prostate cancer (mCRPC)

      • 5.5.3 China Prostate Cancer Treatment Market Size and Growth Rate of Localized prostate cancer

      • 5.5.4 China Prostate Cancer Treatment Market Size and Growth Rate of Metastatic hormone sensitive prostate cancer (mHSPC)

      • 5.5.5 China Prostate Cancer Treatment Market Size and Growth Rate of Recurrence of prostate cancer after curative treatment

    Chapter 6 China Prostate Cancer Treatment Market, by Region

    • 6.1 China Prostate Cancer Treatment Production Volume and Production Value, by Region

    • 6.2 China Prostate Cancer Treatment Sales Volume and Sales Value, by Region

    Chapter 7 North China Prostate Cancer Treatment Market Analysis

    • 7.1 North China Prostate Cancer Treatment Market, by Type

    • 7.2 North China Prostate Cancer Treatment Market, by Application

    Chapter 8 Central China Prostate Cancer Treatment Market Analysis

    • 8.1 Central China Prostate Cancer Treatment Market, by Type

    • 8.2 Central China Prostate Cancer Treatment Market, by Application

    Chapter 9 South China Prostate Cancer Treatment Market Analysis

    • 9.1 South China Prostate Cancer Treatment Market, by Type

    • 9.2 South China Prostate Cancer Treatment Market, by Application

    Chapter 10 East China Prostate Cancer Treatment Market Analysis

    • 10.1 East China Prostate Cancer Treatment Market, by Type

    • 10.2 East China Prostate Cancer Treatment Market, by Application

    Chapter 11 Northeast China Prostate Cancer Treatment Market Analysis

    • 11.1 Northeast China Prostate Cancer Treatment Market, by Type

    • 11.2 Northeast China Prostate Cancer Treatment Market, by Application

    Chapter 12 Southwest China Prostate Cancer Treatment Market Analysis

    • 12.1 Southwest China Prostate Cancer Treatment Market, by Type

    • 12.2 Southwest China Prostate Cancer Treatment Market, by Application

    Chapter 13 Northwest China Prostate Cancer Treatment Market Analysis

    • 13.1 Northwest China Prostate Cancer Treatment Market, by Type

    • 13.2 Northwest China Prostate Cancer Treatment Market, by Application

    Chapter 14 Company Profiles

      • 14.1 AstraZeneca plc

        • 14.1.1 AstraZeneca plc Company Profile

        • 14.1.2 AstraZeneca plc Prostate Cancer Treatment Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Ipsen Pharma

        • 14.2.1 Ipsen Pharma Company Profile

        • 14.2.2 Ipsen Pharma Prostate Cancer Treatment Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Astellas Pharma Inc

        • 14.3.1 Astellas Pharma Inc Company Profile

        • 14.3.2 Astellas Pharma Inc Prostate Cancer Treatment Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Ferring Pharmaceuticals Inc

        • 14.4.1 Ferring Pharmaceuticals Inc Company Profile

        • 14.4.2 Ferring Pharmaceuticals Inc Prostate Cancer Treatment Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Takeda Pharmaceutical Company Ltd

        • 14.5.1 Takeda Pharmaceutical Company Ltd Company Profile

        • 14.5.2 Takeda Pharmaceutical Company Ltd Prostate Cancer Treatment Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 F Hoffmann-La Roche AG

        • 14.6.1 F Hoffmann-La Roche AG Company Profile

        • 14.6.2 F Hoffmann-La Roche AG Prostate Cancer Treatment Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Bristol-Myers Squibb Company

        • 14.7.1 Bristol-Myers Squibb Company Company Profile

        • 14.7.2 Bristol-Myers Squibb Company Prostate Cancer Treatment Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Johnson & Johnson

        • 14.8.1 Johnson & Johnson Company Profile

        • 14.8.2 Johnson & Johnson Prostate Cancer Treatment Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Bayer AG

        • 14.9.1 Bayer AG Company Profile

        • 14.9.2 Bayer AG Prostate Cancer Treatment Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Prostate Cancer Treatment Industry Research Conclusions

    • 15.2 Prostate Cancer Treatment Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Prostate Cancer Treatment Industry Market Size (2018-2029)

    • Figure China Prostate Cancer Treatment Production Volume, Production Value and Growth Rate of Radiochemotherapy (2018-2029)

    • Figure China Prostate Cancer Treatment Production Volume, Production Value and Growth Rate of Other (2018-2029)

    • Figure China Prostate Cancer Treatment Production Volume, Production Value and Growth Rate of Hormone therapy (2018-2029)

    • Figure China Prostate Cancer Treatment Production Volume, Production Value and Growth Rate of Immunotherapy (2018-2029)

    • Figure China Prostate Cancer Treatment Production Volume, Production Value and Growth Rate of Surgery (2018-2029)

    • Figure China Prostate Cancer Treatment Production Volume, Production Value and Growth Rate of Targeted therapy (2018-2029)

    • Figure China Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate of Non metastatic castration resistant prostate cancer (nmCRPC) (2018-2029)

    • Figure China Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate of Metastatic castration resistant prostate cancer (mCRPC) (2018-2029)

    • Figure China Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate of Localized prostate cancer (2018-2029)

    • Figure China Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate of Metastatic hormone sensitive prostate cancer (mHSPC) (2018-2029)

    • Figure China Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate of Recurrence of prostate cancer after curative treatment (2018-2029)

    • Figure North China Prostate Cancer Treatment Market Size and Growth Rate from 2018-2029

    • Figure Central China Prostate Cancer Treatment Market Size and Growth Rate from 2018-2029

    • Figure South China Prostate Cancer Treatment Market Size and Growth Rate from 2018-2029

    • Figure East China Prostate Cancer Treatment Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Prostate Cancer Treatment Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Prostate Cancer Treatment Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Prostate Cancer Treatment Market Size and Growth Rate from 2018-2029

    • Figure Prostate Cancer Treatment Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Prostate Cancer Treatment Market Share by Type in 2018

    • Figure China Prostate Cancer Treatment Market Share by Type in 2023

    • Figure China Prostate Cancer Treatment Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Prostate Cancer Treatment Production Volume and Growth Rate of Radiochemotherapy (2018-2023)

    • Figure China Prostate Cancer Treatment Production Volume and Growth Rate of Other (2018-2023)

    • Figure China Prostate Cancer Treatment Production Volume and Growth Rate of Hormone therapy (2018-2023)

    • Figure China Prostate Cancer Treatment Production Volume and Growth Rate of Immunotherapy (2018-2023)

    • Figure China Prostate Cancer Treatment Production Volume and Growth Rate of Surgery (2018-2023)

    • Figure China Prostate Cancer Treatment Production Volume and Growth Rate of Targeted therapy (2018-2023)

    • Figure China Prostate Cancer Treatment Market Share by Application in 2018

    • Figure China Prostate Cancer Treatment Market Share by Application in 2023

    • Figure China Prostate Cancer Treatment Total Market Size and Growth Rate from Consumption End

    • Figure China Prostate Cancer Treatment Market Size and Growth Rate of Non metastatic castration resistant prostate cancer (nmCRPC) (2018-2023)

    • Figure China Prostate Cancer Treatment Market Size and Growth Rate of Metastatic castration resistant prostate cancer (mCRPC) (2018-2023)

    • Figure China Prostate Cancer Treatment Market Size and Growth Rate of Localized prostate cancer (2018-2023)

    • Figure China Prostate Cancer Treatment Market Size and Growth Rate of Metastatic hormone sensitive prostate cancer (mHSPC) (2018-2023)

    • Figure China Prostate Cancer Treatment Market Size and Growth Rate of Recurrence of prostate cancer after curative treatment (2018-2023)

    • Table China Prostate Cancer Treatment Production Volume by Region (2018-2023)

    • Table China Prostate Cancer Treatment Production Volume Share by Region (2018-2023)

    • Figure China Prostate Cancer Treatment Production Volume Share by Region (2018-2023)

    • Table China Prostate Cancer Treatment Production Value by Region (2018-2023)

    • Table China Prostate Cancer Treatment Production Value Share by Region (2018-2023)

    • Figure China Prostate Cancer Treatment Production Value Share by Region (2018-2023)

    • Table China Prostate Cancer Treatment Sales Volume by Region (2018-2023)

    • Table China Prostate Cancer Treatment Sales Volume Share by Region (2018-2023)

    • Figure China Prostate Cancer Treatment Sales Volume Share by Region (2018-2023)

    • Table China Prostate Cancer Treatment Sales Value by Region (2018-2023)

    • Table China Prostate Cancer Treatment Sales Value Share by Region (2018-2023)

    • Figure China Prostate Cancer Treatment Sales Value Share by Region (2018-2023)

    • Table North China Prostate Cancer Treatment Production Volume by Type (2018-2023)

    • Table North China Prostate Cancer Treatment Production Volume Share by Type (2018-2023)

    • Figure North China Prostate Cancer Treatment Production Volume Share by Type (2018-2023)

    • Table North China Prostate Cancer Treatment Sales Volume by Application (2018-2023)

    • Table North China Prostate Cancer Treatment Sales Volume Share by Application (2018-2023)

    • Figure North China Prostate Cancer Treatment Sales Volume Share by Application (2018-2023)

    • Table Central China Prostate Cancer Treatment Production Volume by Type (2018-2023)

    • Table Central China Prostate Cancer Treatment Production Volume Share by Type (2018-2023)

    • Figure Central China Prostate Cancer Treatment Production Volume Share by Type (2018-2023)

    • Table Central China Prostate Cancer Treatment Sales Volume by Application (2018-2023)

    • Table Central China Prostate Cancer Treatment Sales Volume Share by Application (2018-2023)

    • Figure Central China Prostate Cancer Treatment Sales Volume Share by Application (2018-2023)

    • Table South China Prostate Cancer Treatment Production Volume by Type (2018-2023)

    • Table South China Prostate Cancer Treatment Production Volume Share by Type (2018-2023)

    • Figure South China Prostate Cancer Treatment Production Volume Share by Type (2018-2023)

    • Table South China Prostate Cancer Treatment Sales Volume by Application (2018-2023)

    • Table South China Prostate Cancer Treatment Sales Volume Share by Application (2018-2023)

    • Figure South China Prostate Cancer Treatment Sales Volume Share by Application (2018-2023)

    • Table East China Prostate Cancer Treatment Production Volume by Type (2018-2023)

    • Table East China Prostate Cancer Treatment Production Volume Share by Type (2018-2023)

    • Figure East China Prostate Cancer Treatment Production Volume Share by Type (2018-2023)

    • Table East China Prostate Cancer Treatment Sales Volume by Application (2018-2023)

    • Table East China Prostate Cancer Treatment Sales Volume Share by Application (2018-2023)

    • Figure East China Prostate Cancer Treatment Sales Volume Share by Application (2018-2023)

    • Table Northeast China Prostate Cancer Treatment Production Volume by Type (2018-2023)

    • Table Northeast China Prostate Cancer Treatment Production Volume Share by Type (2018-2023)

    • Figure Northeast China Prostate Cancer Treatment Production Volume Share by Type (2018-2023)

    • Table Northeast China Prostate Cancer Treatment Sales Volume by Application (2018-2023)

    • Table Northeast China Prostate Cancer Treatment Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Prostate Cancer Treatment Sales Volume Share by Application (2018-2023)

    • Table Southwest China Prostate Cancer Treatment Production Volume by Type (2018-2023)

    • Table Southwest China Prostate Cancer Treatment Production Volume Share by Type (2018-2023)

    • Figure Southwest China Prostate Cancer Treatment Production Volume Share by Type (2018-2023)

    • Table Southwest China Prostate Cancer Treatment Sales Volume by Application (2018-2023)

    • Table Southwest China Prostate Cancer Treatment Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Prostate Cancer Treatment Sales Volume Share by Application (2018-2023)

    • Table Northwest China Prostate Cancer Treatment Production Volume by Type (2018-2023)

    • Table Northwest China Prostate Cancer Treatment Production Volume Share by Type (2018-2023)

    • Figure Northwest China Prostate Cancer Treatment Production Volume Share by Type (2018-2023)

    • Table Northwest China Prostate Cancer Treatment Sales Volume by Application (2018-2023)

    • Table Northwest China Prostate Cancer Treatment Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Prostate Cancer Treatment Sales Volume Share by Application (2018-2023)

    • Table AstraZeneca plc Company Profile

    • Table AstraZeneca plc Prostate Cancer Treatment Revenue, Price and Gross (2018-2023)

    • Table Ipsen Pharma Company Profile

    • Table Ipsen Pharma Prostate Cancer Treatment Revenue, Price and Gross (2018-2023)

    • Table Astellas Pharma Inc Company Profile

    • Table Astellas Pharma Inc Prostate Cancer Treatment Revenue, Price and Gross (2018-2023)

    • Table Ferring Pharmaceuticals Inc Company Profile

    • Table Ferring Pharmaceuticals Inc Prostate Cancer Treatment Revenue, Price and Gross (2018-2023)

    • Table Takeda Pharmaceutical Company Ltd Company Profile

    • Table Takeda Pharmaceutical Company Ltd Prostate Cancer Treatment Revenue, Price and Gross (2018-2023)

    • Table F Hoffmann-La Roche AG Company Profile

    • Table F Hoffmann-La Roche AG Prostate Cancer Treatment Revenue, Price and Gross (2018-2023)

    • Table Bristol-Myers Squibb Company Company Profile

    • Table Bristol-Myers Squibb Company Prostate Cancer Treatment Revenue, Price and Gross (2018-2023)

    • Table Johnson & Johnson Company Profile

    • Table Johnson & Johnson Prostate Cancer Treatment Revenue, Price and Gross (2018-2023)

    • Table Bayer AG Company Profile

    • Table Bayer AG Prostate Cancer Treatment Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US